Cancer Research Versailles No Abst  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 5027-5034, October 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giglia, J. S.
Right arrow Articles by Pauly, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giglia, J. S.
Right arrow Articles by Pauly, J. L.

Isolation of Mouse T-Cell Lymphoma Lines from Different Long-Term Interleukin 2-dependent Cultures1

Joseph S. Giglia, Geraldine M. Ovak, M. A. Yoshida2, Carol J. Twist, Amy R. Jeffery and John L. Pauly3

Departments of Molecular Immunology [J. S. G., G. M. O., C. J. T., A. R. J., J. L. P.] and of Genetics and Endocrinology [M. A. Y.], Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263

A number of different biological properties have been ascribed to the hormone-like protein interieukin 2 (IL-2). However, the most salient feature of this lymphokine is its ability to sustain the long-term proliferation of T-cells from humans and mice. Reported herein are the results of studies demonstrating the isolation of growth factor-independent cell lines from the long-term IL-2-dependent murine T-cell line CTLL-2 that is used frequently as the source of target cells in IL-2 bioassays. Sustained logphase growth of these T-cells in vitro has been achieved using Retri dishes of polymethylpentene; growth could not be sustained in similar dishes of glass, untreated polystyrene, polystyrene that had been treated for cell culture, or polycarbonate.

The IL-2-independent line grew as a T-cell lymphoma when injected i.p. into pristane-treated, but not untreated, syngeneic C57BL/6 mice. In contrast, cells from the IL-2 parental line CTLL- 2 did not grow in vivo.

Characterization of the IL-2-independent lines propagated in vitro (denoted as line CEC) or in vivo (denoted as line CEP) demonstrated that they retained their dependency for 2-mercaptoethanol and expressed phenotypic profiles of their parental line CTLL-2 (Thy 1.2+, Lyt-1-; Lyt-2-). Isolation of an IL-2-independent T-cell lymphoma from a CTLL-2 line obtained from another investigator using a protocol that has proven reproducible under carefully controlled laboratory conditions and defined phenotypic traits of the syngeneic T-cell isolates provided evidence that the tumors were not a cross-culture contaminant arising as a result of a laboratory accident. Moreover, karyotypic analysis using a quinacrine: Hoechst banding technique revealed similar marker chromosomes in the IL-2-dependent and -independent lines.

IL-2-independent lines have also been established from the IL-2-dependent murine T-cell line CT-6.

Accordingly, the results of these studies suggest that, during prolonged cultivation that has included exposure to crude IL-2 preparations known to contain phorbol ester, possibly viruses, and other contaminants, the IL-2-dependent lines have developed subpopulations that are thought to have undergone malignant transformation of unknown etiology to generate IL-2-independent murine T-cell lymphomas that can be passaged repetitively either in vitro or in vivo.

1 This work was supported in part by USPHS Grants CA-29635 and CA-38842 and by American Cancer Society Grant IM-389.

2 Present address: Department of Cytogenetics, Medical Research Institute, Tokyo Medical and Dental university, Tokyo 113, Japan.

3 To whom requests for reprints should be addressed.

Received 11/ 9/84. Revised 6/17/85. Accepted 6/25/85.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Huang, S. Gilfillan, M. Cella, M. J. Miley, O. Lantz, L. Lybarger, D. H. Fremont, and T. H. Hansen
Evidence for MR1 Antigen Presentation to Mucosal-associated Invariant T Cells
J. Biol. Chem., June 3, 2005; 280(22): 21183 - 21193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.